Key Stats | |
---|---|
Open | $723.47 |
Prev. Close | $724.87 |
EPS | 5.78 |
Dividend | $4.69 |
Next Earnings Date | Jun 7, 2024 |
Dividend Yield % | 0.71% |
Market Cap | $695.32B |
PE Ratio | 126.90 |
LOW | HIGH | |
---|---|---|
Day Range | 721.00 | 737.45 |
52 Week Range | 370.67 | 800.78 |
Ratios | |
---|---|
P/B Ratio | 66.34 |
Revenue | $34.12B |
Operating M. % | 34.14% |
Earnings | $5.24B |
Earnings Growth % | -16.08% |
EBITDA Margin % | 36.09% |
ROEÂ % | 48.44% |
EPS | 5.78 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
All Score 74 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.
LLY | MARKET | |
---|---|---|
Value | 26 | 40 |
Quality | 69 | 40 |
Ownership | 43 | 17 |
Growth | 75 | 43 |
Dividends | 39 | 38 |
Eli Lilly & Co's Price growth average in the last 3 years of 60.43% is great compared to market average of 6.11%. This indicates LLY could be a good value stock.
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
The current price per share for Eli Lilly & Co (LLY) is $733.51. The stock has seen a price change of $8.64 recently, indicating a 1.19% change. This reflects the stock's recent market performance and investor sentiment.
For Eli Lilly & Co (LLY), the 52-week high is $800.78, which is 9.17% from the current price. The 52-week low is $370.68, the current price is 97.88% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
Eli Lilly & Co (LLY) has shown an average price growth of 59.17% over the past three years. It has received a score of 92 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Eli Lilly & Co as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
As of the latest data, Eli Lilly & Co (LLY) has a year-to-date price change of 23.86%. Over the past month, the stock has experienced a price change of -5.34%. Over the last three months, the change has been 14.75%. Over the past six months, the figure is 29.12%. Looking at a longer horizon, the five-year price change stands at 511.92%.
Eli Lilly & Co (LLY) has a net income of $5.24B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 80.73% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 34.14% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $34.12B, with a revenue growth rate of 19.56%, providing insight into the company's sales performance and growth. The gross profit is $27.55B. Operating income is noted at $10.33B. Furthermore, the EBITDA is $12.46B.
Eli Lilly & Co (LLY) has a market capitalization of $695.32B. The average daily trading volume is 2.44M, indicating the stock's liquidity and investor engagement.
Meta Platforms Stock: Is it a Buy on the Dip?
Natural Language Processing Market Size to Cross the $150B Mark by 2030
The Worst Performers Among Top Cryptos: Polygon and Cardano Brought Losses to 86% and 61% of Investors in 2024
Bitcoin’s 124% 10-Year Annualized Return Tops S&P 500 and Gold, Best Asset of the Decade
Tesla Stock Surges in After-Hours Trading as Company Accelerates Launch of Affordable Vehicles
Digital Wallets to Make 46% of all POS Transactions by 2027
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.